Litigation Details for GIANT EAGLE, INC. v. SOLVAY PHARMACEUTICALS, INC. (W.D. Pa. 2015)
✉ Email this page to a colleague
GIANT EAGLE, INC. v. SOLVAY PHARMACEUTICALS, INC. (W.D. Pa. 2015)
Docket | ⤷ Try a Trial | Date Filed | 2015-05-08 |
Court | District Court, W.D. Pennsylvania | Date Terminated | 2015-05-28 |
Cause | 15:1 Antitrust Litigation | Assigned To | Mark Raymond Hornak |
Jury Demand | Plaintiff | Referred To | |
Patents | 6,503,894 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in GIANT EAGLE, INC. v. SOLVAY PHARMACEUTICALS, INC.
Details for GIANT EAGLE, INC. v. SOLVAY PHARMACEUTICALS, INC. (W.D. Pa. 2015)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2015-05-08 | 1 | Solvay improperly obtained a patent—Patent No. 6,503,894 (the “‘894 patent”)—and used it as a platform… The patent Solvay prosecuted was issued on January 7, 2003 as Patent No. 6,503,894. The patent is directed… outside the scope of Solvay’s ‘894 patent, (2) the ‘894 patent was invalid, and (3) Solvay withheld … the United States Patent and Trademark Office (“PTO”) in obtaining the ‘894 patent. 6. …Notably, had the above-referenced patent litigation proceeded, Solvay’s patent was unlikely to prevent generic | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |